News
Story collection shows interoperability successes
A set of seven stories has been created to demonstrate how biodata and software can be made more interoperable. The stories have been produced by ELIXIR’s Interoperability Platform, a pan-European group of experts working to improve interoperability across the life
Posted:
12 internal projects receive funding of 1.6M euros to support ELIXIR’s scientific strategy
ELIXIR has invested a total of 1.6 million euros in 12 projects to address the scientific priorities of the Scientific Programme 2024-28. The projects form part of three larger initiatives, called Commissioned Services, which support activities that connect experts in
Posted:
New ELIXIR Cancer Data Community to advance cancer data management
ELIXIR has launched a new Cancer Data Community to enhance cancer data accessibility, quality and interoperability. The Community brings together experts across ELIXIR with external partners to coordinate activities and build on ELIXIR’s existing cancer portfolio. Cancer research is highly
Posted:
ELIXIR community meets in Uppsala for All Hands 2024
ELIXIR Sweden were perfect hosts for the tenth annual gathering of the ELIXIR community, held in the splendid surroundings of the historic Uppsala University Main Building. All Hands 2024 brought together 371 in-person attendees and 160 remote participants to share
Posted:
ELIXIR releases 2023 Annual Report
ELIXIR has released its tenth Annual Report, summarising the achievements of the 22 Nodes in the final year of the 2019-2023 Scientific Programme...
Posted:
New Domestic Animals Genome and Phenome Focus Group
A new ELIXIR Focus Group has been created in the area of domestic animal genomics and phenomics research. The group will promote and align tools, databases, standards and best practices, and consider the case for the formation of an ELIXIR
Posted:
New co-leads for ELIXIR scientific priority areas
Following release of the ELIXIR Scientific Programme 2024-28, co-leads for two of the three scientific priority areas have been announced. The third priority, human data and translational research, is to be led by the ELIXIR Hub. The three scientific priority
Posted:
Dublin hosts ELIXIR community for All Hands 2023
Dublin, with its seminal early contributions to bioinformatics, served as an ideal host for the ninth ELIXIR All Hands meeting. The event brought 382 in-person guests and 114 remote attendees to the Dublin Convention Centre between 5-8 June. An important
Posted:
Improving the FAIRification of human copy number variation information
A 24-month project involving ten ELIXIR Nodes has led to improved standardisation of the storage and analysis of human copy number variation (hCNV) data. hCNVs are repeated sections of the genome which vary between individuals and have been found to
Posted:
Measuring the impact of ELIXIR’s training
As a distributed infrastructure, ELIXIR’s training provision is spread throughout ELIXIR’s 22 Nodes. The training aims to enhance data and software skills in the life sciences, for example building expertise in data management, tools, workflows and standards. There are many
Posted:
Building capacity in impact evaluation at ELIXIR
As a publicly funded organisation, it is important that ELIXIR provides evidence of its public value. There are a number of challenges involved in what may seem a straightforward task, including the distributed nature of ELIXIR and a range of
Posted:
ELIXIR community meets in Amsterdam for All Hands 2022
ELIXIR’s eighth All Hands meeting was a welcome return to an in-person gathering after two years of virtual events. The meeting was hosted by ELIXIR Netherlands in the riverside Eye Filmmuseum in Amsterdam and ran for four days between 7
Posted:
Data access, movement and management strategic workshop
As part of ELIXIR’s Strategic Implementation Study on container services, a workshop was held to discuss the current challenges and possible solutions to improving the movement of life science data and how it is accessed and managed. Containers help solve
Posted:
29 new projects funded by ELIXIR
ELIXIR has provided €5.1 million in funding to 29 new projects that launched 1 January 2022. These projects, called ‘Commissioned Services’ are varied in scope and theme, but all aim to provide funding and a method to advance ELIXIR services
Posted:
BY-COVID: A new EU project coordinated by ELIXIR
A new EU funded project coordinated by ELIXIR has been launched today. BY-COVID is a €12million Horizon Europe project striving to tackle the data challenges that can hinder effective pandemic response. This interdisciplinary project involves 53 project partners from across
Posted:
ELIXIR funds seven new life science data projects
Seven new Community-led Implementation Studies were launched on 1 June 2021 covering a diverse range of topics across a variety of life science disciplines. Collectively these projects were awarded €1.5 million, funded through ELIXIR’s Core budget, and will run until
Posted:
Latest Innovation and SME forum sows the seeds of agritech collaboration
Creating technological solutions to agriculture’s biggest problems is a complex practice. Plants grown for agriculture exhibit huge diversity both within and between species; something which can also be influenced by environment and geography. In addition, trying to combat multiple different
Posted:
Hacking the pandemic
Global research community meets online to develop tools for COVID-19 analysis Over 500 scientists, software developers and clinicians joined forces in the COVID-19 virtual Biohackathon to develop new tools for working with the COVID-19 data. The outcomes of the event
Posted:
Hackers meet to develop life science resources
Over 150 bioinformaticians, trainers, software developers and life science enthusiasts travelled from 21 countries across four continents to gather together in Paris, France, for BioHackathon Europe. Participants spent a week in November working collaboratively on over 30 projects aimed at
Posted:
ELIXIR's Industry events a success
Results from a long-term survey and review of the ELIXIR Innovation and SME Forums - specialised events for life science companies and academics - have revealed an overwhelmingly positive impact of the events, with over 93% of participants stating they
Posted: